The standard treatment for symptomatic AD relies primarily on acetyl-cholinesterase (AChE) inhibitors and Aricept is an example of an AChE inhibitor; only a modest effect on the rate of degeneration is afforded by memantine, a glutamate receptor antagonist [4]. Here, ACHE is linked to Alzheimer disease.